Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Branch Retinal Vein Occlusion with Macular Edema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01247220
What this trial is testing

REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Retina Associates of Florida, P.A. 12
Post-approval studies (Phase 4)Study completedNCT01903720
What this trial is testing

A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 71
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT01471691
What this trial is testing

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Who this might be right for
Branch Retinal Vein OcclusionCentral Retinal Vein OcclusionMacular Edema
Hanscom, Thomas, M.D. 14
Large-scale testing (Phase 3)Study completedNCT00486018
What this trial is testing

The Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 397
Testing effectiveness (Phase 2)UnknownNCT01975103
What this trial is testing

Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases

Who this might be right for
Diabetic Macular EdemaBranch Retinal Vein OcclusionChronic Central Serous Retinopathy+1 more
Federal University of Rio Grande do Sul 20
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Post-approval studies (Phase 4)Study completedNCT03709745
What this trial is testing

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion with Macular Edema
St. Erik Eye Hospital 110
Post-approval studies (Phase 4)Study completedNCT01427751
What this trial is testing

Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 307
Post-approval studies (Phase 4)Study completedNCT01085734
What this trial is testing

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusions
Maturi, Raj K., M.D., P.C. 30
Large-scale testing (Phase 3)Study completedNCT01396057
What this trial is testing

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Visual ImpairmentMacular EdemaBranch Retinal Vein Occlusion
Novartis Pharmaceuticals 244
Large-scale testing (Phase 3)Ended earlyNCT03810313
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 493
Post-approval studies (Phase 4)Study completedNCT06708624
What this trial is testing

Ocular Safety and Usability Study for FYB201 PFS

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion with Macular EdemaCentral Retinal Vein Occlusion with Macular Edema
Formycon AG 31
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Testing effectiveness (Phase 2)UnknownNCT01809236
What this trial is testing

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT03108352
What this trial is testing

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Chengdu Kanghong Biotech Co., Ltd. 255
Not applicableUnknownNCT02169648
What this trial is testing

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein OcclusionCentral Retinal Vein Occlusion
Tokyo Medical University 100
Large-scale testing (Phase 3)Study completedNCT01521559
What this trial is testing

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Regeneron Pharmaceuticals 183
Large-scale testing (Phase 3)Study completedNCT00105027
What this trial is testing

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Who this might be right for
Macular Edema, CystoidRetinal Vein Occlusion
The Emmes Company, LLC 682
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Next Page